103 related articles for article (PubMed ID: 2786367)
1. The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: a positron emission tomographic study.
Jarden JO; Dhawan V; Moeller JR; Strother SC; Rottenberg DA
Ann Neurol; 1989 Mar; 25(3):239-45. PubMed ID: 2786367
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of 82Rb: the effect of dexamethasone and whole-brain radiation therapy.
Jarden JO; Dhawan V; Poltorak A; Posner JB; Rottenberg DA
Ann Neurol; 1985 Dec; 18(6):636-46. PubMed ID: 3878686
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological aspects of malignant brain tumors studied with positron emission tomography.
Jarden JO
Acta Neurol Scand Suppl; 1994; 156():1-35. PubMed ID: 7941966
[TBL] [Abstract][Full Text] [Related]
4. Effect of blood curve smearing on the accuracy of parameter estimates obtained for 82Rb/PET studies of blood-brain barrier permeability.
Dhawan V; Jarden JO; Strother S; Rottenberg DA
Phys Med Biol; 1988 Jan; 33(1):61-74. PubMed ID: 3258428
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomographic measurement of blood-to-brain and blood-to-tumour transport of 82Rb. II: Clinical data and validation of technique.
Dhawan V; Jarden JO; Moeller JR; Strother SC; Rottenberg DA
Phys Med Biol; 1989 Dec; 34(12):1785-94. PubMed ID: 2616638
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of brain tumors investigation by positron emission tomography].
Jarden JO
Ugeskr Laeger; 1996 Jul; 158(28):4086-90. PubMed ID: 8701526
[TBL] [Abstract][Full Text] [Related]
7. Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: a positron emission tomographic study.
Phillips PC; Dhawan V; Strother SC; Sidtis JJ; Evans AC; Allen JC; Rottenberg DA
Ann Neurol; 1987 Jan; 21(1):59-63. PubMed ID: 3493728
[TBL] [Abstract][Full Text] [Related]
8. Quantification and pharmacokinetics of blood-brain barrier disruption in humans.
Zünkeler B; Carson RE; Olson J; Blasberg RG; DeVroom H; Lutz RJ; Saris SC; Wright DC; Kammerer W; Patronas NJ; Dedrick RL; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Dec; 85(6):1056-65. PubMed ID: 8929495
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomographic measurement of blood-to-brain and blood-to-tumour transport of 82Rb. I: Error analysis and computer simulations.
Dhawan V; Poltorak A; Moeller JR; Jarden JO; Strother SC; Thaler H; Rottenberg DA
Phys Med Biol; 1989 Dec; 34(12):1773-84. PubMed ID: 2616637
[TBL] [Abstract][Full Text] [Related]
10. Temporal effects of dexamethasone on blood-to-brain and blood-to-tumor transport of 14C-alpha-aminoisobutyric acid in rat C6 glioma.
Shapiro WR; Hiesiger EM; Cooney GA; Basler GA; Lipschutz LE; Posner JB
J Neurooncol; 1990 Jun; 8(3):197-204. PubMed ID: 2358852
[TBL] [Abstract][Full Text] [Related]
11. Brain tumor evaluation using Rb-82 and positron emission tomography.
Yen CK; Yano Y; Budinger TF; Friedland RP; Derenzo SE; Huesman RH; O'Brien HA
J Nucl Med; 1982 Jun; 23(6):532-7. PubMed ID: 6281406
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography.
Brooks DJ; Beaney RP; Lammertsma AA; Leenders KL; Horlock PL; Kensett MJ; Marshall J; Thomas DG; Jones T
J Cereb Blood Flow Metab; 1984 Dec; 4(4):535-45. PubMed ID: 6334092
[TBL] [Abstract][Full Text] [Related]
13. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
[TBL] [Abstract][Full Text] [Related]
14. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors.
Ostergaard L; Hochberg FH; Rabinov JD; Sorensen AG; Lev M; Kim L; Weisskoff RM; Gonzalez RG; Gyldensted C; Rosen BR
J Neurosurg; 1999 Feb; 90(2):300-5. PubMed ID: 9950501
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of brain tumors.
Rozental JM
Neurol Clin; 1991 May; 9(2):287-305. PubMed ID: 1944100
[TBL] [Abstract][Full Text] [Related]
16. Validity of PET studies in brain tumors.
Herholz K; Wienhard K; Heiss WD
Cerebrovasc Brain Metab Rev; 1990; 2(3):240-65. PubMed ID: 2121212
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of blood-brain barrier permeability changes in rhesus monkeys and man using 82Rb and positron emission tomography.
Yen CK; Budinger TF
J Comput Assist Tomogr; 1981 Dec; 5(6):792-9. PubMed ID: 6274931
[TBL] [Abstract][Full Text] [Related]
18. Selective enhancement of intratumoral blood flow in malignant gliomas using intra-arterial adenosine triphosphate.
Baba T; Fukui M; Takeshita I; Ichiya Y; Kuwabara Y; Hasuo K
J Neurosurg; 1990 Jun; 72(6):907-11. PubMed ID: 2338575
[TBL] [Abstract][Full Text] [Related]
19. Measurement of blood-brain and blood-tumor barrier permeabilities with [14C]-labeled tracers.
Asotra K; Ningaraj N; Black KL
Methods Mol Med; 2003; 89():177-90. PubMed ID: 12958420
[No Abstract] [Full Text] [Related]
20. [Vascular response in brain tumor--investigation by positron emission tomography].
Tomura N; Uemura K; Shishido F; Inugami A; Higano S; Fujita H; Kanno I; Kato T
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Oct; 47(10):1314-6. PubMed ID: 3502022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
